Affordable Access

Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction <or=30%.

Authors
  • Pitt, Bertram
  • Gheorghiade, Mihai
  • Zannad, Faiez
  • Anderson, Jeffrey L
  • van Veldhuisen, Dirk J
  • Parkhomenko, Alexander
  • Corbalan, Ramon
  • Klug, Eric Q
  • Mukherjee, Robin
  • Solomon, Henry
Type
Published Article
Journal
European journal of heart failure
Publication Date
May 01, 2006
Volume
8
Issue
3
Pages
295–301
Identifiers
PMID: 16504579
Source
Medline
License
Unknown

Abstract

Treatment with eplerenone plus standard therapy in patients with post-AMI HF and LVEF <or=30% provided significant incremental benefits in reducing both early and late mortality and morbidity.

Report this publication

Statistics

Seen <100 times